Filing Details

Accession Number:
0001593968-18-001282
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-02 10:42:00
Reporting Period:
2018-09-30
Accepted Time:
2018-10-02 10:42:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466026 Midland States Bancorp Inc. MSBI State Commercial Banks (6022) 371233196
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1526231 M John Schultz 1201 Network Centre Dr.
Effingham IL 62401
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-01 1,000 $31.92 285,426 No 4 S Direct
Common Stock Disposition 2018-10-01 1,000 $31.92 69,903 No 4 S Indirect JNJ, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect JNJ, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Share Equivalent Acquisiton 2018-09-30 442 $32.10 442 $0.00
Common Stock Common Share Equivalent Acquisiton 2018-09-30 110 $32.10 110 $0.00
Common Stock Common Share Equivalent Acquisiton 2018-09-30 399 $32.10 399 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,695 No 4 A Direct
58,806 No 4 A Direct
59,205 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,750 Indirect Spouse
Common Stock 42,554 Indirect Agracel, Inc.
Footnotes
  1. Includes holdings through a self-directed IRA or revocable grantor trust
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.9001 - $31.9250 inclusive. The reporting person undertakes to provide to Midland States Bancorp, Inc., any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote to this form.
  3. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose
  4. No exercise price for this type of award
  5. Represents common share equivalents acquired by the reporting person under the Issuers Directors Deferred Compensation Plan (DDCP) with respect to director fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees fully vested on the transaction date listed above and become payable upon termination of service as a director.
  6. Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution.
  7. Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates.
  8. Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director.